The Medicine Maker / Power List / 2018

The Power List 2018

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks. And that’s why we have once again divided our annual Power List of the top 100 inspirational industry professionals into four categories: Masters of the Bench, Industry Influencers, Business Captains, and Champions of Change.

The illustrious members of each group contribute, in various ways, to the life-changing, and often life-saving, work carried out by the biopharmaceutical industry. It is our great pleasure to present to you The Medicine Maker 2018 Power List, which was compiled based on nominations from readers and the input of an expert judging panel.

Masters of the Bench

Robert Samuel Langer

Institute Professor, Massachusetts Institute of Technology, Langer Lab

Christopher J.H. Porter

Professor and Director, Monash Institute of Pharmaceutical Sciences

Carl June

Richard W. Vague Professor in Immunotherapy, University of Pennsylvania

David Baltimore

President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology

Roderick MacKinnon

Scientific Co-Founder and Co-Chair, Flex Pharma

Nicholas A. Peppas

Professor and Director of the Institute for Biomaterials, Drug Delivery and Regenerative Medicine, The University of Texas at Austin

Shinya Yamanaka

Director and Professor, Center for iPS Cell Research

Michael N. Liebman

Managing Director and Founder, IPQ Analytics LLC

Andreas Seidel-Morgenstern

Director, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg

Chi Van Dang

Scientific Director, Ludwig Cancer Research

Phil S. Baran

Darlene Shiley Chair in Chemistry, Scripps Research Institute

Jonathan Bones

Principal Investigator, NIBRT Characterization and Comparability Laboratory

Chas Bountra

Professor of Translational Medicine, Nuffield Department of Clinical Medicine, University of Oxford

Carolyn Bertozzi

Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, Stanford University

Jonas Boström

Principal Scientist, AstraZeneca; Chief Executive Officer, EduChem VR

Meindert Danhof

Retired

David Dunger

Professor of Pediatrics, University of Cambridge

Kenneth Getz

Associate Professor and Director of Sponsored Programs, Center for the Study of Drug Development, Tufts University School of Medicine; Founder and Board Chair, CISCRP

Graziella Pellegrini

Cell Therapy Program Coordinator, center for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia

Claus-Michael Lehr

Head, Department of Drug Delivery, Helmholtz-Institute for Pharmaceutical Research Saarland, Helmholtz Center for Infection Research (HZI), Saarland University

Michele De Luca

Director, center for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia

Peter Seeberger

Director, Max-Planck-Institute of Colloids and Interfaces; Professor, Free University of Berlin

Dolores Schendel

Chief Executive Officer and Chief Scientific Officer, Medigene

Harold Varmus

Lewis Thomas University Professor & Senior Advisor to the Dean and Provost, Weill Cornell Medical College

John Talley

Chief Scientific Officer, Euclises Pharmaceuticals

Industry Influencers

Richard Johnson

Chief Executive Officer and President, Parenteral Drug Association

Martin VanTrieste

Immediate Past Chair, Parenteral Drug Association

Andy Skibo

Head of Global Biologics Operations & Global Engineering, AstraZeneca/Medimmune

Michael W. Vandiver

Vice President of Manufacturing & Plant Design, Just Biotherapeutics

Rino Rappuoli

Chief Scientist and Head External R&D, GSK Vaccines

Gil Roth

President, Pharma & Biopharma Outsourcing Association

John Bournas

President and Chief Executive officer, ISPE

Cornell Stamoran

Vice President, Catalent

Jim Breen

Vice President, Worldwide Engineering and Technical Operations, Johnson & Johnson

Moncef Slaoui

Partner, Medicxi

James Agalloco

President, Agalloco & Associates

Harold Baseman

Chief Operating Officer, ValSource

Gary Cunnington

Global Head of CTSU Business Consultancy, Boehringer Ingelheim

Madhavan (Madhu) Balachandran

Business Owner, mjb Consultants

Marc Bisschops

Director Continuous Bioprocessing, Pall Biotech

Miguel Forte

Chief Executive Officer, Zelluna Immunotherapy and Chief Commercialization Officer and Chair of Commercialization Committee, International Society of Cellular Therapy

Fiona Greer

Global Director, BioPharma Services Development, SGS

Ajaz Hussain

Founder and Chief Executive Officer, Insight, Advice and Solutions; President, National Institute for Pharmaceutical Technology and Education

Maik Jornitz

Chief Executive Officer, G-Con Manufacturing

Carol Lynch

President Sandoz Inc and Head of North America

Daniel O’Connor

Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency

Guido Rasi

Executive Director, European Medicines Agency

Ram Sasisekharan

Alfred H. Caspary Professor of Biological Engineering and Health Sciences & Technology, MIT Department of Biological Engineering

Thomas Ryll

Vice President of Technical Operations, Immunogen

Andrew Witty

Chief Executive, Optum (effective July 1, 2018)

Business Captains

Kiran Mazumdar-Shaw

Chairperson and Managing Director, Biocon

Joseph Jimenez

Former Chief Executive Officer, Novartis

Raman Singh

Chief Executive Officer, Mundipharma, Singapore

Emma Walmsley

Chief Executive Officer, GlaxoSmithKline

Belén Garijo

Chief Executive Officer, Healthcare, Merck

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

Severin Schwan

Chief Executive Officer, Roche Group

Arie Belldegrun

Executive Chairman and Co-Founder, Allogene Therapeutics

Jean-Paul Clozel

Chief Executive Officer, Idorsia

Rachel Haurwitz

President and Chief Executive Officer, Caribou Biosciences

Stéphane Bancel

Chief Executive Officer, Moderna Therapeutics

Erik Gatenholm

Co-Founder and Chief Executive Officer, CELLINK

Stéphane Boissel

Chief Executive officer, TxCell

John Chiminski

President and Chief Executive Officer, Catalent

Annalisa Jenkins

Chief Executive Officer, PlaqueTec

Jeff Jonas

Chief Executive Officer, Sage Therapeutics

Ankit Mahadevia

President and Chief Executive Officer, Spero Therapeutics

Rodger Novak

President and Co-Founder, CRISPR Therapeutics

G. V. Prasad

Co-Chairman and Chief Executive Officer, Dr. Reddy’s Laboratories

Vivek Ramaswamy

Founder and Chief Executive Officer, Roivant Sciences

Ravi Nalliah

Co-Founder and Chief Executive Officer, TrakCel

Ian C. Read

Chairman of the Board and Chief Executive officer, Pfizer

Leonard Schleifer

President and Chief Executive Officer, Regeneron

David Schenkein

Chief Executive Officer, Agios Pharmaceuticals

Martin Tolar

Founder, President and Chief Executive Officer, Alzheon

Champions of Change

Tomasz Sablinski

Chief Executive Officer and Co-founder, Transparency Life Sciences

J. Craig Venter

Founder, Chairman and Chief Executive Officer, J. Craig Venter Institute

Steve Davis

President and Chief Executive Officer, Path; Lecturer on Social Innovation, Stanford Graduate School of Business

Andrew Pollard

Professor of Pediatric Infection and Immunity, University of Oxford

Anthony S. Fauci

Director, US National Institute of Allergy and Infectious Diseases (NIAID)

Sue Desmond

Hellmann Chief Executive Officer, Bill & Melinda Gates Foundation

Subhash Kapre

Chief Executive Officer, Inventprise

Julie Louise

Gerberding Executive Vice President, Communications, Global policy, and Population Health & Chief Patient Officer, Merck, Sharp & Dohme

Margaret Hamburg

President, AAAS, Foreign secretary of National Academy of Medicine

Mark Paxton

Managing Director, AcceleratoRx

Steve Arlington

President, Pistoia Alliance

Ségolène Aymé

Emeritus Director of Research, French Institute of Health and Medical Research (INSERM)

Dario Campana

Mrs. Lee Kong Chian Chair in Advanced Cellular Therapy, Professor, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore; Scientific Founder, Unum Therapeutics, Nkarta and Medisix Therapeutics

Thomas Cech

Distinguished Professor of Chemistry and Biochemistry, University of Colorado

Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate Biopharma

Ben Goldacre

Senior Clinical Research Fellow, Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences

Faith Osier

Group Leader, Heidelberg University Hospital; Principal Investigator, Kemri-Wellcome Trust Research Program

Brian Overstreet

President, Advera Health Analytics

Mike Rea

Chief Executive Officer, IDEA Pharma

Melinda Richter

Global Head of JLABS, Johnson & Johnson

Robin Robinson